Dysplastic Nevus Syndrome clinical trials
The registry lists 24 studies for Dysplastic Nevus Syndrome across 9 countries. 7 are recruiting or about to start. 15 of them are mainly about Dysplastic Nevus Syndrome (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-29.
Get an email when these change. Save the Dysplastic Nevus Syndrome studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Orlucent, Inc (3) · National Cancer Institute (NCI) (2) · John Kirkwood (2) · Region Skane (1) · Nova Scotia Health Authority (1) · Rutgers, The State University of New Jersey (1) · Aristotle University Of Thessaloniki (1) · Assuta Hospital Systems (1)
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 2
- Dec 2026BioMEL- Diagnostic and Prognostic Factors in Melanoma. · Region Skane
- Jul 2027The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics · H. Lee Moffitt Cancer Center and Research Institute
Who these studies take
Of the 6 Dysplastic Nevus Syndrome studies recruiting now, 4 (67%) set no upper age limit and 0 (0%) stop at 75 or younger. 1 (17%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (17%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (17%) | 1 (17%) |
| 18 | 6 (100%) | 6 (100%) |
| 30 | 6 (100%) | 6 (100%) |
| 40 | 6 (100%) | 6 (100%) |
| 50 | 6 (100%) | 6 (100%) |
| 65 | 6 (100%) | 6 (100%) |
| 75 | 6 (100%) | 6 (100%) |
| 85 | 5 (83%) | 5 (83%) |
Across all 24 studies, recruiting or not: 8% stop at 75 or younger and 4% at 65; 21% take children; 0% are for women only and 0% for men only; 46% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 24 of 24. search them.
- Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of MelanomaRecruitingNCT000403521 country
- The Cancer of the Pancreas Screening-5 CAPS5)StudyRecruitingNCT02000089Phase 31 country
- Sulforaphane for the Prevention of Melanoma in Patients With Multiple Atypical Nevi and a Prior History of MelanomaRecruitingNCT07040280Phase 21 country
- Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic NeviRecruitingNCT065996191 country
- INTER-PATHOLOGIST READER STUDYEnrolling by invitationNCT062469031 country
- BioMEL- Diagnostic and Prognostic Factors in Melanoma.RecruitingNCT054461551 country
- Registry of Subjects at Risk of Pancreatic CancerRecruitingNCT040951951 country
- The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel TherapeuticsActive, not recruitingNCT056925961 country
- Pancreatic Cancer Early Detection ProgramCompletedNCT022063601 country
- Skin Fluorescent Imaging (SFI) System in Patients With NeviCompletedNCT043682471 country
- Genetic Identification (ID) of Segmental Dysplastic NeviWithdrawnNCT009555781 country
- Assessing Tissue Remodeling in the Skin Using SFI (Skin Fluorescence Imaging)CompletedNCT035350771 country
- Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin DamageTerminatedNCT046887491 country
- Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for MelanomaCompletedNCT03725449Not applicable1 country
- Optical Biopsy of Human Skin in Conjunction With Laser TreatmentCompletedNCT005405661 country
- Atypical MOLes and Melanoma Early Detection Study (MoleMed)Status unknownNCT04353050Not applicable1 country
- A Study of IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk GroupsCompletedNCT036933785 countries
- Evaluation of 20% Betulinic Acid Ointment for Treatment of Dysplastic Nevi (Moderate to Severe Dysplasia)WithdrawnNCT00346502Phase 1/21 country
- Family Study of Melanoma in ItalyCompletedNCT003392222 countries
- Prospective Study of 2 mm Margins for the Biopsy of Dysplastic NeviCompletedNCT030942731 country
- Potential Research Study Participant RegistryCompletedNCT007104891 country
- Artificial Intelligence-assisted Evaluation of Pigmented Skin LesionsStatus unknownNCT033621381 country
- Pilot Study Evaluating Sulforaphane in Atypical Nevi-Precursor LesionsCompletedNCT01568996Early Phase 11 country
- Photochemical Tissue BondingCompletedNCT00586040Phase 21 country